Skip to content

Yellow fever vaccine in HIV-positive people: safe, but not always effective

Highlights from CROI 2009

HIV testing and prevention

PMTCT and maternal health

Opportunistic infections: prophylaxis and management

Prevention technologies

Treatment switches on basis of CD4 declines often unnecessary, Uganda research shows

Disadvantage of late treatment start in Africa may persist for years, studies find

Hepatitis C in HIV-positive gay men: Amsterdam, Paris, New York and UK compared